Bacillus Calmette-Guerin (BCG) Vaccine Clinical Trials

• Revaccination of Young Children with Bacille Calmette Guerin (BCG) Vaccine
  ClinicalTrials.gov Identifier: NCT00126217 - Active, not recruiting
  Malaria
  
• Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine
  ClinicalTrials.gov Identifier: NCT00168610 - Active, not recruiting
  Infant Mortality; Morbidity
  
• Should Low Birth Weight Infants Be Vaccinated with BCG Vaccine at Birth in Developing Countries
  ClinicalTrials.gov Identifier: NCT00146302 - Recruiting
  Mortality; Morbidity
  
• Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure
  ClinicalTrials.gov Identifier: NCT00109655 - Recruiting
  Carcinoma, Transitional Cell; Bladder Neoplasms
  
• The Effect of Bacille Calmette Guerin (BCG) Vaccination on Immune Responses in HIV-Exposed and Unexposed Infants
  ClinicalTrials.gov Identifier: NCT00331474 - Recruiting
  HIV Infections
  
• Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
  ClinicalTrials.gov Identifier: NCT00234039 - Recruiting
  Recurrent Bladder Cancer; Stage 0 Bladder Cancer; Stage I Bladder Cancer; Transitional Cell Carcinoma of the Bladder
  
• Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed
  ClinicalTrials.gov Identifier: NCT00170469 - Active, not recruiting
  Bacillus Anthracis (Anthrax)
  
• Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00003023 - Active, not recruiting
  childhood soft tissue sarcoma; Muscle Cancer; Neuroblastoma; Osteosarcoma
  
• Vitamin A With BCG Vaccine
  ClinicalTrials.gov Identifier: NCT00168597 - Active, not recruiting
  Mortality; Morbidity
  
• UMD rPA Regimen Trial
  ClinicalTrials.gov Identifier: NCT00133484 - Terminated
  Bacillus anthracis (anthrax)
  
• A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG
  ClinicalTrials.gov Identifier: NCT00465465 - Active, not recruiting
  Tuberculosis
  
• Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00007826 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Vaccine Therapy in Treating Patients With Transitional Cell Cancer of the Bladder
  ClinicalTrials.gov Identifier: NCT00070070 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage I bladder cancer
  
• BCG Vaccine and Morbidity from Malaria.
  ClinicalTrials.gov Identifier: NCT00131794 - Completed
  Malaria
  
• Vaccine Therapy Compared With Interferon alfa in Treating Patients With Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00003715 - Active, not recruiting
  stage III melanoma
  
• Phase II Study of Range and Schedule of rPA Doses
  ClinicalTrials.gov Identifier: NCT00170456 - Active, not recruiting
  Bacillus Anthracis (Anthrax)
  
• Surgery and BCG in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00002990 - Active, not recruiting
  stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder
  
• Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00152802 - Active, not recruiting
  transplant
  
• BCG With or Without Mitomycin in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00023842 - Active, not recruiting
  stage 0 bladder cancer; recurrent bladder cancer; transitional cell carcinoma of the bladder
  
• ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in Children
  ClinicalTrials.gov Identifier: NCT00457353 - Recruiting
  Gastroenteritis
  
• Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.
  ClinicalTrials.gov Identifier: NCT00242047 - Active, not recruiting
  Tuberculosis
  
• Monoclonal Antibody for Treatment of Inhalation Anthrax
  ClinicalTrials.gov Identifier: NCT00138411 - Completed
  Bacillus anthracis (anthrax)
  
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00013871 - Active, not recruiting
  HIV Infections; Hepatitis B; Measles; Pneumococcal Infections; Pertussis
  
• Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006352 - Active, not recruiting
  limited stage small cell lung cancer
  
• Study of Anti-HIV Therapy Intensification
  ClinicalTrials.gov Identifier: NCT00034086 - Active, not recruiting
  HIV Infections
  
• Kidney Transplants in People with HIV Infection
  ClinicalTrials.gov Identifier: NCT00023478 - Active, not recruiting
  HIV Infections; End-Stage Renal Disease
  
• Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age
  ClinicalTrials.gov Identifier: NCT00242424 - Active, not recruiting
  Inactivated Influenza Vaccine
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Diphtheria, Tetanus & Pertussis Vaccine (DTaP) Vaccine & a Haemophilus Influenza Type B (Hib) Vaccine in Healthy Children 15 m of Age
  ClinicalTrials.gov Identifier: NCT00197236 - Active, not recruiting
  Hepatitis A
  
• Vaccine Therapy in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003184 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination
  ClinicalTrials.gov Identifier: NCT00143780 - Active, not recruiting
  Bone Marrow Transplant
  
• A Study to Test the Safety of Three Experimental HIV Vaccines
  ClinicalTrials.gov Identifier: NCT00000946 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• BCG Vaccine Oral Intradermal
  ClinicalTrials.gov Identifier: NCT00396370 - Suspended
  Tuberculosis
  
• Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00061243 - Active, not recruiting
  HIV Infections
  
• Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors
  ClinicalTrials.gov Identifier: NCT00216814 - Recruiting
  Bladder Cancer
  
• Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella, and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month Old Children
  ClinicalTrials.gov Identifier: NCT00312858 - Active, not recruiting
  Hepatitis A
  
• Recombinant CMV gB Vaccine in Postpartum Women
  ClinicalTrials.gov Identifier: NCT00125502 - Active, not recruiting
  Cytomegalovirus Infections
  
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00009958 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants
  ClinicalTrials.gov Identifier: NCT00000829 - Active, not recruiting
  HIV Infections; Pneumococcal Infections
  
• Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00030693 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment
  ClinicalTrials.gov Identifier: NCT00138385 - Active, not recruiting
  Influenza
  
• Safety and Immunogenicity of Smallpox Vaccine MVA-BN
  ClinicalTrials.gov Identifier: NCT00082446 - Active, not recruiting
  Smallpox
  
• Hyperthermia Treatment in Conjunction With Mitomycin C Versus BCG for Superficial Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00384891 - Recruiting
  Carcinoma, Transitional Cell/Therapy
  
• Safety and Immunogenicity of Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants.
  ClinicalTrials.gov Identifier: NCT00130832 - Active, not recruiting
  Rotavirus disease
  
• Vaccine Therapy in Treating Patients With Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00128583 - Active, not recruiting
  stage III melanoma
  
• Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00091702 - Active, not recruiting
  HIV Infections; Influenza
  
• Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
  ClinicalTrials.gov Identifier: NCT00125008 - Active, not recruiting
  Typhoid; Paratyphoid Fever
  
• Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
  ClinicalTrials.gov Identifier: NCT00131833 - Active, not recruiting
  Typhoid; Paratyphoid Fever
  
• Safety of and Immune Response to a DNA HIV Vaccine Followed By an Adenoviral Vector HIV Vaccine in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00125970 - Active, not recruiting
  HIV Infections
  
• CDC Anthrax Vaccine Clinical Trial
  ClinicalTrials.gov Identifier: NCT00119067 - Active, not recruiting
  Healthy
  
• Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue
  ClinicalTrials.gov Identifier: NCT00131820 - Active, not recruiting
  Typhoid; Paratyphoid Fever
  
• Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents
  ClinicalTrials.gov Identifier: NCT00325130 - Active, not recruiting
  Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Meningitis
  
• Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00141999 - Active, not recruiting
  Hepatitis
  
• Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
  ClinicalTrials.gov Identifier: NCT00005052 - Active, not recruiting
  stage II melanoma
  
• Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder
  ClinicalTrials.gov Identifier: NCT00539773 - Active, not recruiting
  Transitional Carcinoma of Urinary Bladder
  
• Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine
  ClinicalTrials.gov Identifier: NCT00164411 - Active, not recruiting
  Pneumococcal Infections
  
• Study to Evaluate Four Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as One Dose to Children Aged 12 to 14 Months and 3 to 5 Years Old
  ClinicalTrials.gov Identifier: NCT00126984 - Active, not recruiting
  Meningitis, Meningococcal
  
• Vaccine Therapy for Patients with Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00052156 - Active, not recruiting
  Malignant Melanoma
  
• PPD Size and Mycobacteria Tuberculosis ELISPOT in Children Who Have Received BCG in Neonate Period
  ClinicalTrials.gov Identifier: NCT00172783 - Recruiting
  Tuberculosis
  
• URO-BCG-4 : Bladder Tumors Immunotherapy
  ClinicalTrials.gov Identifier: NCT00213655 - Recruiting
  Bladder Cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00087373 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• An Investigational Combination Vaccine Given to People Who Are Not Infected with HIV
  ClinicalTrials.gov Identifier: NCT00027365 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003761 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016146 - Active, not recruiting
  recurrent prostate cancer
  
• Influenza Vaccine in Pediatric Transplant Subjects
  ClinicalTrials.gov Identifier: NCT00133510 - Active, not recruiting
  Influenza
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00022568 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Immunotherapy in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003432 - Active, not recruiting
  stage IV breast cancer
  
• Vaccine Therapy in Preventing Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
  ClinicalTrials.gov Identifier: NCT00128661 - Active, not recruiting
  Cervical Cancer; high-grade squamous intraepithelial lesion
  
• A Study to Test 2 Doses of GSK Biologicals'' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly with Routine EPI Vaccinations Including OPV in Healthy Infants.
  ClinicalTrials.gov Identifier: NCT00139347 - Active, not recruiting
  Prophylaxis rotavirus
  
• Vaccine Therapy Plus Biological Therapy in Treating Patients With Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016120 - Active, not recruiting
  recurrent prostate cancer
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Immunotherapy of Melanoma Patients
  ClinicalTrials.gov Identifier: NCT00112216 - Recruiting
  Melanoma
  
• Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
  ClinicalTrials.gov Identifier: NCT00125047 - Active, not recruiting
  Typhoid; Paratyphoid Fever
  
• Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
  ClinicalTrials.gov Identifier: NCT00030823 - Active, not recruiting
  Breast Cancer; Male Breast Cancer
  
• Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00004052 - Active, not recruiting
  relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Vaccine Therapy in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00003665 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-Refractory Patients With Non-Muscle Invasive Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00406068 - Recruiting
  Bladder Neoplasms
  
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00010127 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate
  
• A Dose-Escalation Vaccine Trial In HER2-Overexpressing Patients With High-Risk Breast Cancer
  ClinicalTrials.gov Identifier: NCT00058526 - Active, not recruiting
  Breast Cancer
  
• Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients
  ClinicalTrials.gov Identifier: NCT00112229 - Recruiting
  Melanoma
  
• Consistency Lots Vaccine Study
  ClinicalTrials.gov Identifier: NCT00092456 - Active, not recruiting
  Rotavirus Infections
  
• Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities
  ClinicalTrials.gov Identifier: NCT00311649 - Active, not recruiting
  Influenza
  
• Immunologic Memory (Supp. of ATN 024)
  ClinicalTrials.gov Identifier: NCT00142753 - Active, not recruiting
  Healthy subjects; HIV Infection
  
• A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years
  ClinicalTrials.gov Identifier: NCT00006509 - Active, not recruiting
  HIV Infections
  
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• A Study in Infants to Test Two Preparations (Freeze-Dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).
  ClinicalTrials.gov Identifier: NCT00382772 - Active, not recruiting
  Gastroenteritis
  
• A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group
  ClinicalTrials.gov Identifier: NCT00000815 - Active, not recruiting
  HIV Infections; Measles
  
• Vaccine Therapy in Treating Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00052988 - Active, not recruiting
  stage I melanoma; stage II melanoma; stage III melanoma
  
• An Investigational Vaccine in Reducing the Incidence of Anogenital Warts in Young Men
  ClinicalTrials.gov Identifier: NCT00090285 - Active, not recruiting
  Condylomata Acuminata
  
• Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers
  ClinicalTrials.gov Identifier: NCT00103584 - Active, not recruiting
  Smallpox
  
• Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata
  ClinicalTrials.gov Identifier: NCT00119197 - Active, not recruiting
  Cholera
  
• A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age
  ClinicalTrials.gov Identifier: NCT00092391 - Active, not recruiting
  Measles; Mumps; Rubella; Varicella
  
• Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
  ClinicalTrials.gov Identifier: NCT00048386 - Active, not recruiting
  Neuroblastoma
  
• A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chicken Pox)
  ClinicalTrials.gov Identifier: NCT00130793 - Active, not recruiting
  Herpes Zoster
  
• Vaccine Therapy in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00033228 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy for Patients with Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00052130 - Active, not recruiting
  Malignant Melanoma
  
• Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00003222 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy with Or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, Or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00118313 - Active, not recruiting
  stage II melanoma; stage III melanoma; Stage IV Melanoma
  
• Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children with Weakened Immune Systems
  ClinicalTrials.gov Identifier: NCT00006066 - Active, not recruiting
  HIV Infections
  
• Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00039325 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Safety, Tolerability, and Immunogenicity Study of a C Difficile Toxoid Vaccine in Healthy Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00127803 - Active, not recruiting
  Clostridium Difficile